Balrampur Chini Mills is one of India's largest integrated sugar companies, with distillery and cogeneration businesses, and is building India's first commercial Polylactic Acid (PLA) plant. This lean crushing quarter's print will speak to sugar realizations against a firm price environment, and to the PLA plant's October (lactic acid) and December (PLA) commissioning timeline alongside the unresolved ethanol pricing overhang.
| Results date | November 04, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 1,636.79 Cr |
| Previous quarter PAT | Rs. 38.59 Cr (Standalone) |
| Previous quarter EBITDA margin | 6.96% |
| Market cap | Rs. 12,476.28 Cr |
| CMP | Rs. 589.5 |
The Board of Balrampur Chini Mills meets on 04-Nov-2026 to consider the unaudited standalone and consolidated financial results for Q2/H1 FY27 (quarter and half-year ended 30-Sep-2026) and the declaration of the FY27 interim dividend with record date fixation.
The 04-Nov-2026 Board meeting agenda includes declaration of the FY27 interim dividend along with record date fixation. The dividend amount has not been disclosed; FY26 saw an interim dividend of Rs. 3.50 per share.
The quarter under review (July-September 2026) is seasonally the lean crushing period, so the swing factor is price rather than volume, with ex-mill sugar realizations far above the Rs. 37.19/kg carrying value of the 45.67 lakh quintal inventory even after government intervention pulled rates back from a record ~Rs. 67/kg on 18-Aug to Rs. 45-50.
Cost pressures built through the window: maize at Rs. 27/kg versus Rs. 17-18/kg a year ago squeezes the grain-based distillery runs that carry the off-season quarter, while molasses-route ethanol prices stay frozen (C-heavy Rs. 57.97/L unchanged for ESY 2026-27) and juice/syrup/B-heavy were excluded from the ESY 2026-27 tender just after quarter-close. The PLA segment's pre-commissioning PBIT loss of Rs. 9.84 Cr in Q1 FY27 should persist, with capex of about Rs. 2,180 crore spent by end-July 2026 ahead of the October (lactic acid) and December (PLA) commissioning targets.
On the season ahead, monsoon rainfall was 87% of LPA (4th lowest since 2001), the USDA cut its India 2026-27 sugar production estimate to 29.5 MMT, and FRP for the new season is set at Rs. 365/quintal. The upcoming call is likely to cover the sugar realization bridge, the quantified impact of the zero-diversion ethanol order, PLA commissioning confirmation, and the FY27 interim dividend.
PLA commissioning and ramp status: India's first commercial PLA plant (80,000 TPA / 250 TPD at Kumbhi) is the pivotal catalyst.
Ethanol pricing and diversion policy: Ethanol pricing remains the dominant unresolved headwind.
Sugar realizations and 2026-27 season view: Firm prices against a low-cost inventory base frame the quarter's margin story.
Preferential issue deployment and corporate actions: Deployment of the Rs. 450 Cr preferential issue and the interim dividend are on the agenda.
Management said 'definitely yes. I think we could' when asked whether INR 3,000 to INR 3,200 crore of capex could create a parallel Balrampur. The company has guided ~40% average PLA capacity utilization for January-March, with the internal target higher.
Management was asked whether ~10 crore litres from C-heavy plus 9-10 crore litres from grains is achievable next season, and said policy must come first but added 'What he says looks like it is accurate'. FY28 volume and mix guidance remains deferred pending government policy.
Management declined to give tonnage or addressable-market numbers, calling the market 'very large' but saying it would be irresponsible to quantify without verified figures. Technical trials for gutkha/pan masala packaging have been successful, with results expected over the next two to three months.
The commissioning target was originally Q3FY27, restated as H2FY27, and refined on the Q1 FY27 call to October for lactic acid and December for PLA. About Rs. 2,180 crore of the ~Rs. 3,080 crore capex had been spent by end-July 2026.
Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.